NSCLC
-
Fosun (Foritinib) – NSCLC | HongKong DengYue Medicine
-
Hansizhuang (Serplulimab) – Solid Tumors | HongKong DengYue Medicine
-
Haiyitan (Glumetinib) – Lung Cancer (NSCLC) | HongKong DengYue Medicine
-
Saimeina (Befotertinib) – NSCLC | HongKong DengYue Medicine
-
Mektovi (Binimetinib) – Melanoma | HongKong DengYue Medicine
-
Hernexeos (Zongertinib) – NSCLC | HongKong DengYue Medicine
-
Avastin (Bevacizumab) – mCRC & NSCLC | HongKong DengYue Medicine
-
Conmana (Icotinib) – NSCLC | HongKong DengYue Medicine
-
Xalkori (Crizotinib) – NSCLC | HongKong DengYue Medicine
-
Iressa (Gefitinib) – NSCLC | HongKong DengYue Medicine
-
Airuikai (Glecirasib Citrate) – NSCLC | HongKong DengYue Medicine
-
Aoyixin (Limertinib) – NSCLC | HongKong DengYue Medicine
-
TEPMETKO (Tepotinib) – NSCLC | HongKong DengYue Medicine
-
Tafinlar (Dabrafenib Mesylate) – Melanoma & Lung Cancer | DengYue Medicine
-
Tabrecta (Capmatinib) – NSCLC | DengYue Medicine
-
Rezivertinib – NSCLC | HongKong DengYue Medicine
Copyright@ 2016-2024 Hong Kong Deng Yue Med Al Rights